Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lupin to market Forest's AeroChamber Plus in the US

This article was originally published in Scrip

Executive Summary

Lupinhas signed a multi-year agreement with Forest Laboratoriesto promote and market Forest's AeroChamber Plus line of products in the US. AeroChamber Plus is a valved holding chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and chronic obstructive pulmonary disease. Lupin's US subsidiary will use its 50-person sales force to promote the product to paediatricians. The company also expects the alliance to help extend its presence in the respiratory segment and strengthen its franchise with paediatricians. AeroChamber Plus is the most widely prescribed holding chamber in the US and about two thirds of AeroChamber Plus VHC prescriptions (IMS 2007) are written by paediatricians.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC031173

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel